Kathleen Ford - May 19, 2025 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
Chief Operating Officer
Signature
Teresa Bair, Attorney-in-fact for Kathleen Ford
Stock symbol
KURA
Transactions as of
May 19, 2025
Transactions value $
-$9,777
Form type
4
Date filed
5/19/2025, 06:30 PM
Previous filing
Jan 28, 2025
Next filing
Sep 29, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
FORD KATHLEEN Chief Operating Officer C/O KURA ONCOLOGY, INC., 12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO Teresa Bair, Attorney-in-fact for Kathleen Ford 2025-05-19 0001785406

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KURA Common Stock Sale -$9.78K -1.56K -6.8% $6.28 21.4K May 19, 2025 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2024.
F2 1,558 shares were acquired on May 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan.
F3 This transaction was executed in multiple trades at prices ranging from $6.27 to $6.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.